Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Abstract

Inflammatory bowel disease (IBD) is a group of chronic inflammatory gastrointestinal diseases that causes worldwide suffering. L. helveticus is a probiotic that can enhance intestinal barrier function via alleviation of excessive inflammatory response. Citrulline, a functional amino acid, has been reported to stimulate muscle synthesis and to function with a prebiotic-like action with certain Lactobacillus strains. The aim of this study was to investigate the potential synergistic effect of combining L. helveticus and citrulline on protection against damage induced by dextran sulfate sodium (DSS) in a mouse model. 6-week-old male C57BL/6J mice were fed with DSS water and randomly divided for administering with different milk treatments: 1) plain milk (control or DSS control), 2) 1% (w/v) citrulline enriched milk (Cit_milk), 3) milk fermented with L. helveticus (LHFM) and 4) DSS+milk fermented with L. helveticus with 1% (w/v) citrulline (Cit_LHFM). The treatment effects on the survival and macroscopic and microscopic signs were examined. All treatments presented different degrees of protective effects on attenuating the damages induced by DSS. All treatments reduced the body weight loss, disease activity index (DAI), histological scores, pro-inflammatory cytokine expression (IL-6, TNF-α and IFN-γ) and production (IL-4) (all P <0.05) and the tight junction (TJ) protein (zonula occluden-1 (ZO-1) expression. LHFM and Cit_LHFM improved survival rate (both at P<0.05). Particularly, Cit_LHFM showed greater effects on protecting the damages induced by DSS, especially in ameliorating colonic permeability, TJ protein (ZO-1, occludin and claudin-1) expression and distribution as well as in reducing IL-4 and IL-17 expression (all P <0.05). Our findings suggested that the combination of and citrulline had significant synergistic effect on protecting against injury from DSS-induced colitis. Therefore, citrulline enriched L. helveticus fermented milk is suggested to be a potential therapy for treating IBD.

Keywords: Dextran sulfate sodium induced colitis; L-citrulline; L. helveticus; fermented milk with La. helveticus; inflammation; tight junction proteins.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus helveticusImproved Survival RateBeneficial
Moderate
Lactobacillus helveticusImproved Tight Junction Protein ExpressionBeneficial
Large
Lactobacillus helveticusReduced Body WeightBeneficial
Moderate
Lactobacillus helveticusReduced Colonic PermeabilityBeneficial
Large
Lactobacillus helveticusReduced Disease ActivityBeneficial
Moderate
Lactobacillus helveticusReduced Histological ScoresBeneficial
Moderate
Lactobacillus helveticusReduced Pro-Inflammatory CytokinesBeneficial
Moderate
Lactobacillus helveticus HA-128Improved Survival RateBeneficial
Moderate
Lactobacillus helveticus HA-128Reduced Body WeightBeneficial
Moderate
Lactobacillus helveticus HA-128Reduced Disease Activity Index (DAI) LevelsBeneficial
Moderate
Lactobacillus helveticus L10Improved Survival RateBeneficial
Moderate
Lactobacillus helveticus L10Improved Tight Junction Protein ExpressionBeneficial
Large
Lactobacillus helveticus L10Reduced Body WeightBeneficial
Moderate
Lactobacillus helveticus L10Reduced Colonic PermeabilityBeneficial
Large
Lactobacillus helveticus L10Reduced Disease Activity Index (DAI) LevelsBeneficial
Moderate
Lactobacillus helveticus L10Reduced Histological ScoresBeneficial
Moderate
Lactobacillus helveticus L10Reduced Pro-Inflammatory CytokinesBeneficial
Moderate
Lactobacillus helveticus LH76Improved Survival RateBeneficial
Moderate
Lactobacillus helveticus LH76Improved Tight Junction Protein ExpressionBeneficial
Large
Lactobacillus helveticus LH76Reduced Body WeightBeneficial
Moderate
Lactobacillus helveticus LH76Reduced Colonic PermeabilityBeneficial
Large
Lactobacillus helveticus LH76Reduced Disease Activity Index (DAI) LevelsBeneficial
Moderate
Lactobacillus helveticus LH76Reduced Histological ScoresBeneficial
Moderate
Lactobacillus helveticus LH76Reduced IL-17 ExpressionBeneficial
Large
Lactobacillus helveticus LH76Reduced Interleukin-4 ProductionBeneficial
Moderate
Lactobacillus helveticus LH76Reduced Pro-Inflammatory CytokinesBeneficial
Moderate
Lactobacillus helveticus R0052Improved Disease Activity Index ScoreBeneficial
Moderate
Lactobacillus helveticus R0052Improved Survival RateBeneficial
Moderate
Lactobacillus helveticus R0052Improved Tight Junction Protein ExpressionBeneficial
Large
Lactobacillus helveticus R0052Reduced Body WeightBeneficial
Moderate
Lactobacillus helveticus R0052Reduced Colonic PermeabilityBeneficial
Large
Lactobacillus helveticus R0052Reduced Pro-Inflammatory CytokinesBeneficial
Moderate
Lactobacillus helveticus Rosell-52Improved Survival RateBeneficial
Moderate
Lactobacillus helveticus Rosell-52Improved Tight Junction Protein ExpressionBeneficial
Large
Lactobacillus helveticus Rosell-52Reduced Body WeightBeneficial
Moderate
Lactobacillus helveticus Rosell-52Reduced Colonic PermeabilityBeneficial
Large
Lactobacillus helveticus Rosell-52Reduced Disease ActivityBeneficial
Moderate
Lactobacillus helveticus Rosell-52Reduced Histological ScoresBeneficial
Moderate
Lactobacillus helveticus Rosell-52Reduced IL-17 ExpressionBeneficial
Large
Lactobacillus helveticus Rosell-52Reduced Interleukin-4 ProductionBeneficial
Moderate
Lactobacillus helveticus Rosell-52Reduced Pro-Inflammatory CytokinesBeneficial
Moderate
Lactobacillus helveticus Rosell-52 MEImproved Survival RateBeneficial
Moderate
Lactobacillus helveticus Rosell-52 MEImproved Tight Junction Protein ExpressionBeneficial
Large
Lactobacillus helveticus Rosell-52 MEReduced Body WeightBeneficial
Moderate
Lactobacillus helveticus Rosell-52 MEReduced Colonic PermeabilityBeneficial
Large
Lactobacillus helveticus Rosell-52 MEReduced Disease ActivityBeneficial
Moderate
Lactobacillus helveticus Rosell-52 MEReduced Histological ScoresBeneficial
Moderate
Lactobacillus helveticus Rosell-52 MEReduced IL-17 ExpressionBeneficial
Large
Lactobacillus helveticus Rosell-52 MEReduced Interleukin-4 ProductionBeneficial
Moderate
Lactobacillus helveticus Rosell-52 MEReduced Pro-Inflammatory CytokinesBeneficial
Moderate
Lactobacillus helveticus Rosell-52NDImproved Survival RateBeneficial
Moderate
Lactobacillus helveticus Rosell-52NDImproved Tight Junction Protein ExpressionBeneficial
Large
Lactobacillus helveticus Rosell-52NDReduced Body WeightBeneficial
Moderate
Lactobacillus helveticus Rosell-52NDReduced Colonic PermeabilityBeneficial
Large
Lactobacillus helveticus Rosell-52NDReduced Disease ActivityBeneficial
Moderate
Lactobacillus helveticus Rosell-52NDReduced Histological ScoresBeneficial
Moderate
Lactobacillus helveticus Rosell-52NDReduced Pro-Inflammatory CytokinesBeneficial
Moderate
Lactobacillus helveticus VPro 13Improved Intestinal Barrier FunctionBeneficial
Large
Lactobacillus helveticus VPro 13Improved Survival RateBeneficial
Moderate
Lactobacillus helveticus VPro 13Reduced Colonic DamageBeneficial
Large
Lactobacillus helveticus VPro 13Reduced Inflammation LevelsBeneficial
Large
Back to top